SYH-2070

N/A

Report date: 2026/05/24 20:00:34
NME

Base Information

Drug NameSYH-2070
Drug Alias NameSYH2070SYH-2070
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionAngiopoietin like 3 inhibitors
TargetsAngiopoietin like 3
Therapy Area/IndicationsHomozygous familial hypercholesterolemiaHypertriglyceridemiaHyperlipidemias +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesCspc Heibei Zhongrun Pharmaceutiacl Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesCSPC Pharmaceutical Group LtdCSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co LtdCspc Heibei Zhongrun Pharmaceutiacl Co Ltd
Inactive CompaniesN/A
Active IndicationsHomozygous familial hypercholesterolemiaHypertriglyceridemiaHyperlipidemias +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A